nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfentanil—ABCB1—peripheral nervous system neoplasm	0.358	1	CbGaD
Alfentanil—CYP3A7-CYP3A51P—Tretinoin—peripheral nervous system neoplasm	0.0687	0.134	CbGbCtD
Alfentanil—CYP3A7—Tretinoin—peripheral nervous system neoplasm	0.0687	0.134	CbGbCtD
Alfentanil—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0516	0.1	CbGbCtD
Alfentanil—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0361	0.0703	CbGbCtD
Alfentanil—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0361	0.0703	CbGbCtD
Alfentanil—CYP3A7—Vincristine—peripheral nervous system neoplasm	0.0316	0.0615	CbGbCtD
Alfentanil—CYP3A7-CYP3A51P—Vincristine—peripheral nervous system neoplasm	0.0316	0.0615	CbGbCtD
Alfentanil—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.025	0.0487	CbGbCtD
Alfentanil—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0237	0.0461	CbGbCtD
Alfentanil—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0217	0.0422	CbGbCtD
Alfentanil—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0216	0.0421	CbGbCtD
Alfentanil—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0201	0.0392	CbGbCtD
Alfentanil—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0154	0.03	CbGbCtD
Alfentanil—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0144	0.028	CbGbCtD
Alfentanil—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0141	0.0275	CbGbCtD
Alfentanil—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00963	0.0188	CbGbCtD
Alfentanil—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00923	0.018	CbGbCtD
Alfentanil—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00846	0.0165	CbGbCtD
Alfentanil—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00577	0.0112	CbGbCtD
Alfentanil—Pain—Melphalan—peripheral nervous system neoplasm	0.00033	0.00256	CcSEcCtD
Alfentanil—Cardiac disorder—Cisplatin—peripheral nervous system neoplasm	0.00033	0.00256	CcSEcCtD
Alfentanil—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.000325	0.00252	CcSEcCtD
Alfentanil—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.000322	0.0025	CcSEcCtD
Alfentanil—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.000322	0.0025	CcSEcCtD
Alfentanil—Agitation—Vincristine—peripheral nervous system neoplasm	0.000322	0.0025	CcSEcCtD
Alfentanil—Immune system disorder—Cisplatin—peripheral nervous system neoplasm	0.000321	0.00249	CcSEcCtD
Alfentanil—Mediastinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00032	0.00249	CcSEcCtD
Alfentanil—Loss of consciousness—Alitretinoin—peripheral nervous system neoplasm	0.000319	0.00248	CcSEcCtD
Alfentanil—Arrhythmia—Cisplatin—peripheral nervous system neoplasm	0.000318	0.00246	CcSEcCtD
Alfentanil—Cough—Alitretinoin—peripheral nervous system neoplasm	0.000317	0.00246	CcSEcCtD
Alfentanil—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.000315	0.00244	CcSEcCtD
Alfentanil—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.000314	0.00243	CcSEcCtD
Alfentanil—Urticaria—Topotecan—peripheral nervous system neoplasm	0.000313	0.00243	CcSEcCtD
Alfentanil—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.000312	0.00242	CcSEcCtD
Alfentanil—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.000311	0.00241	CcSEcCtD
Alfentanil—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.000311	0.00241	CcSEcCtD
Alfentanil—Erythema—Cisplatin—peripheral nervous system neoplasm	0.000309	0.0024	CcSEcCtD
Alfentanil—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.000309	0.0024	CcSEcCtD
Alfentanil—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.000309	0.0024	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.000307	0.00238	CcSEcCtD
Alfentanil—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000307	0.00238	CcSEcCtD
Alfentanil—Eye disorder—Etoposide—peripheral nervous system neoplasm	0.000304	0.00236	CcSEcCtD
Alfentanil—Convulsion—Vincristine—peripheral nervous system neoplasm	0.000303	0.00235	CcSEcCtD
Alfentanil—Cardiac disorder—Etoposide—peripheral nervous system neoplasm	0.000302	0.00235	CcSEcCtD
Alfentanil—Hypertension—Vincristine—peripheral nervous system neoplasm	0.000302	0.00235	CcSEcCtD
Alfentanil—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.000299	0.00232	CcSEcCtD
Alfentanil—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.000296	0.0023	CcSEcCtD
Alfentanil—Angiopathy—Etoposide—peripheral nervous system neoplasm	0.000295	0.00229	CcSEcCtD
Alfentanil—Immune system disorder—Etoposide—peripheral nervous system neoplasm	0.000294	0.00228	CcSEcCtD
Alfentanil—Mediastinal disorder—Etoposide—peripheral nervous system neoplasm	0.000294	0.00228	CcSEcCtD
Alfentanil—Chills—Etoposide—peripheral nervous system neoplasm	0.000292	0.00227	CcSEcCtD
Alfentanil—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.000292	0.00226	CcSEcCtD
Alfentanil—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000291	0.00226	CcSEcCtD
Alfentanil—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00029	0.00225	CcSEcCtD
Alfentanil—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.000289	0.00225	CcSEcCtD
Alfentanil—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000288	0.00224	CcSEcCtD
Alfentanil—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000288	0.00224	CcSEcCtD
Alfentanil—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000288	0.00223	CcSEcCtD
Alfentanil—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.000287	0.00222	CcSEcCtD
Alfentanil—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.000286	0.00222	CcSEcCtD
Alfentanil—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000284	0.00221	CcSEcCtD
Alfentanil—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000283	0.0022	CcSEcCtD
Alfentanil—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000281	0.00218	CcSEcCtD
Alfentanil—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000281	0.00218	CcSEcCtD
Alfentanil—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.00028	0.00217	CcSEcCtD
Alfentanil—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000279	0.00217	CcSEcCtD
Alfentanil—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000277	0.00215	CcSEcCtD
Alfentanil—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000277	0.00215	CcSEcCtD
Alfentanil—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000277	0.00215	CcSEcCtD
Alfentanil—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000277	0.00215	CcSEcCtD
Alfentanil—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000276	0.00214	CcSEcCtD
Alfentanil—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000276	0.00214	CcSEcCtD
Alfentanil—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000273	0.00212	CcSEcCtD
Alfentanil—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000273	0.00212	CcSEcCtD
Alfentanil—Anaphylactoid reaction—Epirubicin—peripheral nervous system neoplasm	0.000273	0.00212	CcSEcCtD
Alfentanil—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000268	0.00208	CcSEcCtD
Alfentanil—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000267	0.00207	CcSEcCtD
Alfentanil—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000264	0.00205	CcSEcCtD
Alfentanil—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000263	0.00204	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000262	0.00203	CcSEcCtD
Alfentanil—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000261	0.00202	CcSEcCtD
Alfentanil—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000259	0.00201	CcSEcCtD
Alfentanil—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000259	0.00201	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000256	0.00199	CcSEcCtD
Alfentanil—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000256	0.00198	CcSEcCtD
Alfentanil—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000253	0.00197	CcSEcCtD
Alfentanil—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000253	0.00196	CcSEcCtD
Alfentanil—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000253	0.00196	CcSEcCtD
Alfentanil—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.00196	CcSEcCtD
Alfentanil—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.000251	0.00195	CcSEcCtD
Alfentanil—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000251	0.00195	CcSEcCtD
Alfentanil—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000249	0.00193	CcSEcCtD
Alfentanil—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000249	0.00193	CcSEcCtD
Alfentanil—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000249	0.00193	CcSEcCtD
Alfentanil—Rash—Topotecan—peripheral nervous system neoplasm	0.000249	0.00193	CcSEcCtD
Alfentanil—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000248	0.00193	CcSEcCtD
Alfentanil—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000248	0.00192	CcSEcCtD
Alfentanil—Cough—Etoposide—peripheral nervous system neoplasm	0.000247	0.00192	CcSEcCtD
Alfentanil—Headache—Topotecan—peripheral nervous system neoplasm	0.000247	0.00192	CcSEcCtD
Alfentanil—Rash—Tretinoin—peripheral nervous system neoplasm	0.000247	0.00191	CcSEcCtD
Alfentanil—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000247	0.00191	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000247	0.00191	CcSEcCtD
Alfentanil—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000246	0.00191	CcSEcCtD
Alfentanil—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000246	0.00191	CcSEcCtD
Alfentanil—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000246	0.00191	CcSEcCtD
Alfentanil—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000246	0.00191	CcSEcCtD
Alfentanil—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000246	0.00191	CcSEcCtD
Alfentanil—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000245	0.00191	CcSEcCtD
Alfentanil—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000245	0.0019	CcSEcCtD
Alfentanil—Headache—Tretinoin—peripheral nervous system neoplasm	0.000245	0.0019	CcSEcCtD
Alfentanil—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000245	0.0019	CcSEcCtD
Alfentanil—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000245	0.0019	CcSEcCtD
Alfentanil—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000244	0.0019	CcSEcCtD
Alfentanil—Pain—Vincristine—peripheral nervous system neoplasm	0.000244	0.0019	CcSEcCtD
Alfentanil—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000244	0.00189	CcSEcCtD
Alfentanil—Rash—Melphalan—peripheral nervous system neoplasm	0.000243	0.00189	CcSEcCtD
Alfentanil—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000243	0.00189	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.00024	0.00186	CcSEcCtD
Alfentanil—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000236	0.00183	CcSEcCtD
Alfentanil—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000236	0.00183	CcSEcCtD
Alfentanil—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000235	0.00183	CcSEcCtD
Alfentanil—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000234	0.00182	CcSEcCtD
Alfentanil—Nausea—Topotecan—peripheral nervous system neoplasm	0.000234	0.00182	CcSEcCtD
Alfentanil—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000233	0.00181	CcSEcCtD
Alfentanil—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000232	0.0018	CcSEcCtD
Alfentanil—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000232	0.0018	CcSEcCtD
Alfentanil—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000232	0.0018	CcSEcCtD
Alfentanil—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000231	0.0018	CcSEcCtD
Alfentanil—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000229	0.00178	CcSEcCtD
Alfentanil—Nausea—Melphalan—peripheral nervous system neoplasm	0.000229	0.00178	CcSEcCtD
Alfentanil—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000226	0.00175	CcSEcCtD
Alfentanil—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000226	0.00175	CcSEcCtD
Alfentanil—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000225	0.00174	CcSEcCtD
Alfentanil—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000224	0.00174	CcSEcCtD
Alfentanil—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000218	0.00169	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000218	0.00169	CcSEcCtD
Alfentanil—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000216	0.00168	CcSEcCtD
Alfentanil—Pain—Cisplatin—peripheral nervous system neoplasm	0.000216	0.00168	CcSEcCtD
Alfentanil—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000213	0.00165	CcSEcCtD
Alfentanil—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00021	0.00163	CcSEcCtD
Alfentanil—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00021	0.00163	CcSEcCtD
Alfentanil—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000208	0.00162	CcSEcCtD
Alfentanil—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000206	0.0016	CcSEcCtD
Alfentanil—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000205	0.00159	CcSEcCtD
Alfentanil—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000203	0.00158	CcSEcCtD
Alfentanil—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000203	0.00158	CcSEcCtD
Alfentanil—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000202	0.00156	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.0002	0.00155	CcSEcCtD
Alfentanil—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.0002	0.00155	CcSEcCtD
Alfentanil—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000199	0.00155	CcSEcCtD
Alfentanil—Pain—Etoposide—peripheral nervous system neoplasm	0.000198	0.00154	CcSEcCtD
Alfentanil—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000196	0.00152	CcSEcCtD
Alfentanil—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000192	0.00149	CcSEcCtD
Alfentanil—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000191	0.00148	CcSEcCtD
Alfentanil—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00019	0.00147	CcSEcCtD
Alfentanil—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000189	0.00147	CcSEcCtD
Alfentanil—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000188	0.00146	CcSEcCtD
Alfentanil—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.00146	CcSEcCtD
Alfentanil—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000187	0.00145	CcSEcCtD
Alfentanil—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000187	0.00145	CcSEcCtD
Alfentanil—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000186	0.00144	CcSEcCtD
Alfentanil—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000186	0.00144	CcSEcCtD
Alfentanil—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000186	0.00144	CcSEcCtD
Alfentanil—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000184	0.00143	CcSEcCtD
Alfentanil—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000183	0.00142	CcSEcCtD
Alfentanil—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000182	0.00141	CcSEcCtD
Alfentanil—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000181	0.00141	CcSEcCtD
Alfentanil—Rash—Vincristine—peripheral nervous system neoplasm	0.00018	0.0014	CcSEcCtD
Alfentanil—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00018	0.0014	CcSEcCtD
Alfentanil—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000179	0.00139	CcSEcCtD
Alfentanil—Headache—Vincristine—peripheral nervous system neoplasm	0.000179	0.00139	CcSEcCtD
Alfentanil—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.00138	CcSEcCtD
Alfentanil—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000176	0.00137	CcSEcCtD
Alfentanil—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000176	0.00137	CcSEcCtD
Alfentanil—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.00133	CcSEcCtD
Alfentanil—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000171	0.00132	CcSEcCtD
Alfentanil—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00017	0.00132	CcSEcCtD
Alfentanil—Nausea—Vincristine—peripheral nervous system neoplasm	0.00017	0.00132	CcSEcCtD
Alfentanil—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000169	0.00131	CcSEcCtD
Alfentanil—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000166	0.00129	CcSEcCtD
Alfentanil—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.00129	CcSEcCtD
Alfentanil—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000166	0.00129	CcSEcCtD
Alfentanil—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000165	0.00128	CcSEcCtD
Alfentanil—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000165	0.00128	CcSEcCtD
Alfentanil—Chills—Epirubicin—peripheral nervous system neoplasm	0.000164	0.00127	CcSEcCtD
Alfentanil—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000164	0.00127	CcSEcCtD
Alfentanil—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000163	0.00127	CcSEcCtD
Alfentanil—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.00126	CcSEcCtD
Alfentanil—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000161	0.00125	CcSEcCtD
Alfentanil—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.00016	0.00124	CcSEcCtD
Alfentanil—Rash—Cisplatin—peripheral nervous system neoplasm	0.000159	0.00124	CcSEcCtD
Alfentanil—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000159	0.00123	CcSEcCtD
Alfentanil—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000159	0.00123	CcSEcCtD
Alfentanil—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.00123	CcSEcCtD
Alfentanil—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.00122	CcSEcCtD
Alfentanil—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.00119	CcSEcCtD
Alfentanil—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000153	0.00119	CcSEcCtD
Alfentanil—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.00118	CcSEcCtD
Alfentanil—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.00118	CcSEcCtD
Alfentanil—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.00118	CcSEcCtD
Alfentanil—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.00117	CcSEcCtD
Alfentanil—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00015	0.00116	CcSEcCtD
Alfentanil—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.00015	0.00116	CcSEcCtD
Alfentanil—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.00115	CcSEcCtD
Alfentanil—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000147	0.00114	CcSEcCtD
Alfentanil—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.00114	CcSEcCtD
Alfentanil—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000146	0.00113	CcSEcCtD
Alfentanil—Rash—Etoposide—peripheral nervous system neoplasm	0.000146	0.00113	CcSEcCtD
Alfentanil—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000146	0.00113	CcSEcCtD
Alfentanil—Headache—Etoposide—peripheral nervous system neoplasm	0.000145	0.00112	CcSEcCtD
Alfentanil—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.00014	0.00108	CcSEcCtD
Alfentanil—Cough—Epirubicin—peripheral nervous system neoplasm	0.000139	0.00108	CcSEcCtD
Alfentanil—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.00108	CcSEcCtD
Alfentanil—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000138	0.00107	CcSEcCtD
Alfentanil—Nausea—Etoposide—peripheral nervous system neoplasm	0.000137	0.00107	CcSEcCtD
Alfentanil—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000137	0.00106	CcSEcCtD
Alfentanil—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.00105	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000134	0.00104	CcSEcCtD
Alfentanil—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000131	0.00101	CcSEcCtD
Alfentanil—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.00013	0.00101	CcSEcCtD
Alfentanil—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.001	CcSEcCtD
Alfentanil—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000996	CcSEcCtD
Alfentanil—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000989	CcSEcCtD
Alfentanil—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000987	CcSEcCtD
Alfentanil—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000985	CcSEcCtD
Alfentanil—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000982	CcSEcCtD
Alfentanil—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000978	CcSEcCtD
Alfentanil—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000973	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000965	CcSEcCtD
Alfentanil—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000941	CcSEcCtD
Alfentanil—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000939	CcSEcCtD
Alfentanil—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000931	CcSEcCtD
Alfentanil—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000913	CcSEcCtD
Alfentanil—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000909	CcSEcCtD
Alfentanil—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000905	CcSEcCtD
Alfentanil—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.0009	CcSEcCtD
Alfentanil—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000895	CcSEcCtD
Alfentanil—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.00087	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000869	CcSEcCtD
Alfentanil—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000868	CcSEcCtD
Alfentanil—Pain—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000861	CcSEcCtD
Alfentanil—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000107	0.00083	CcSEcCtD
Alfentanil—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000828	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000804	CcSEcCtD
Alfentanil—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000803	CcSEcCtD
Alfentanil—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000103	0.0008	CcSEcCtD
Alfentanil—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000796	CcSEcCtD
Alfentanil—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000796	CcSEcCtD
Alfentanil—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	9.89e-05	0.000768	CcSEcCtD
Alfentanil—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	9.56e-05	0.000742	CcSEcCtD
Alfentanil—Urticaria—Doxorubicin—peripheral nervous system neoplasm	9.53e-05	0.00074	CcSEcCtD
Alfentanil—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	9.49e-05	0.000736	CcSEcCtD
Alfentanil—Asthenia—Epirubicin—peripheral nervous system neoplasm	9.31e-05	0.000722	CcSEcCtD
Alfentanil—Pruritus—Epirubicin—peripheral nervous system neoplasm	9.18e-05	0.000712	CcSEcCtD
Alfentanil—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	8.84e-05	0.000686	CcSEcCtD
Alfentanil—Asthenia—Doxorubicin—peripheral nervous system neoplasm	8.61e-05	0.000668	CcSEcCtD
Alfentanil—Dizziness—Epirubicin—peripheral nervous system neoplasm	8.58e-05	0.000666	CcSEcCtD
Alfentanil—Pruritus—Doxorubicin—peripheral nervous system neoplasm	8.49e-05	0.000659	CcSEcCtD
Alfentanil—Vomiting—Epirubicin—peripheral nervous system neoplasm	8.25e-05	0.00064	CcSEcCtD
Alfentanil—Rash—Epirubicin—peripheral nervous system neoplasm	8.18e-05	0.000635	CcSEcCtD
Alfentanil—Dermatitis—Epirubicin—peripheral nervous system neoplasm	8.17e-05	0.000634	CcSEcCtD
Alfentanil—Headache—Epirubicin—peripheral nervous system neoplasm	8.12e-05	0.000631	CcSEcCtD
Alfentanil—Dizziness—Doxorubicin—peripheral nervous system neoplasm	7.94e-05	0.000616	CcSEcCtD
Alfentanil—Nausea—Epirubicin—peripheral nervous system neoplasm	7.7e-05	0.000598	CcSEcCtD
Alfentanil—Vomiting—Doxorubicin—peripheral nervous system neoplasm	7.63e-05	0.000592	CcSEcCtD
Alfentanil—Rash—Doxorubicin—peripheral nervous system neoplasm	7.57e-05	0.000587	CcSEcCtD
Alfentanil—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	7.56e-05	0.000587	CcSEcCtD
Alfentanil—Headache—Doxorubicin—peripheral nervous system neoplasm	7.52e-05	0.000583	CcSEcCtD
Alfentanil—Nausea—Doxorubicin—peripheral nervous system neoplasm	7.13e-05	0.000553	CcSEcCtD
